Resistance in Gram negative bacteriae: What is the current situation?

##plugins.themes.academic_pro.article.sidebar##

Published Oct 5, 2012
Download
pdf
Vol. 90 No. 10 (2012): Issue Oct 2012

##plugins.themes.academic_pro.article.main##

Dalèle Elhani
Ichrak Elhani
Mahjoub Aouni

Abstract

Emergence of antibiotic resistance put an end to the antibiotic miracle. According to recent review data, the number of cases of multiresistant bacteria, which are resistant to all antibiotics available, is increasing as well in the developed countries as in the developing countries. To face the emergence of these bacteria, it is necessary to evaluate the situation in Tunisian hospitals and act consequently.
This review provide recent data on antibiotic resistance in Gram negative bacilli in Tunisian hospitals by focusing on some emergent resistances, which represent a daily challenge for the medical profession, such as extended spectrum beta-lactamases, carbapenem resistance, and fluoroquinolone resistance.

Keywords:

Antibiotic resistance, Tunisia, Gram Negative bacilli

##plugins.themes.academic_pro.article.details##

References

  1. HAWKEY PM. The growing burden of antimicrobial resistance. J Antimicrob Chemother. 2008;62 Suppl 1:i1-9.
  2. MULVEY MR, SIMOR AE. Antimicrobial resistance in hospitals: how concerned should we be? CMAJ 2009;180:408-15.
  3. LIVERMORE DM. Has the era of untreatable infections arrived? J Antimicrob Chemother. 2009;64 Suppl 1:i29-36.
  4. RUPPE E. Epidémiologie des bêta-lactamases à spectre élargi : l'avènement des CTX-M. Antibiotique. 2010 ; 12 : 3-16.
  5. PATERSON DL, BONOMO RA. Extended spectrum ßlactamases: a clinical update. Clin Microbiol Rev. 2005; 18: 657- 686.
  6. PHILIPPON A, BEN REDJEB S, FOURNIER G, BEN HASSEN A. Epidemiology of extended spectrum ß-lactamases. Infection 1989; 17: 347-5.
  7. BOUALLÈGUE-GODET O, GRIMONT F, BEN SALEM Y et al. Investigation of the clonal dissemination of Klebsiella pneumoniae isolates producing extended-spectrum betalactamases in a neonatal ward, Sousse, Tunisia. Pathol Biol (Paris) 2005; 53: 75-80.
  8. KTARI S, ARLET G, MNIF B et al. Emergence of multidrugresistant Klebsiella pneumoniae isolates producing VIM-4 metallo-beta-lactamase, CTX-M-15 extended-spectrum betalactamase, and CMY-4 AmpC beta-lactamase in a Tunisian university hospital. Antimicrob Agents Chemother 2006;50:4198- 201.
  9. BEN JABALLAH N, BOUZIRI A, MNIF K, HAMDI A, KHALDI A, KCHAOU W. Epidemiology of hospital-acquired bloodstream infections in a Tunisian paediatric intensive care unit: a 2-year prospective study. Am J Infect Control 2007; 35: 613-618.
  10. ELHANI D, BAKIR L, AOUNI M et al. Molecular epidemiology of extended-spectrum ß-lactamase-producing Klebsiella pneumoniae strains in a university hospital in Tunis, Tunisia,1999-2005. Clin Microbiol Infect 2010;16:157-164.
  11. ELHANI D, BAKIR L, AOUNI M. Dissémination des souches de Klebsiella pneumoniae productrices de ‚-lactamases à spectre étendu dans un centre hospitalo-universitaire tunisien. Ann Biol Clin 2006; 64: 237-43.
  12. ABBASSI MS, TORRES C, ACHOUR W et al. Genetic characterisation of CTX-M-15-producing Klebsiella pneumoniae and Escherichia coli strains isolated from stem cell transplant patients in Tunisia. Int J Antimicrob Agents 2008; 32: 308-14.
  13. SMAOUI H, MAHJOUBI F, BOUTIBA I et al. Sensibilité aux antibiotiques des souches urinaires d'E. coli: Résultats d'une étude multicentrique. Tunis Med. 2003; 81:390-4.
  14. LARABI K, MASMOUDI A, FENDRI C. Etude bactériologique et phénotypes de résistance des germes responsables d'infections urinaires dans un CHU de Tunis : à propos de 1930 cas. Med Mal Infect 2003; 33:348-52.
  15. THABET L, MESSADI A, MBAREK M, TURKI A, MEDDEB B, BEN REDJEB S. Surveillance des bactéries multi résistantes aux antibiotiques dans un hôpital tunisien. Tunis Med. 2008; 86: 992-5.
  16. ABBASSI MS, TORRES C, ACHOUR W et al. Genetic characterisation of CTX-M-15-producing Klebsiella pneumoniae and Escherichia coli strains isolated from stem cell transplant patients in Tunisia. Int J Antimicrob Agents 2008; 32: 308-14.
  17. MESSAI L, ACHOUR W, BEN HASSEN A. Profil épidémiologique des entérobactéries isolées chez des patients neutropéniques. Pathol Biol (Paris) 2007;55:230-4.
  18. CHOUCHANI C, BEN ACHOUR N, M'CHAREK A, BELHADJ O. First characterization in Tunisia of a TEM-15, extendedspectrum beta-lactamase-producing Klebsiella pneumoniae isolate. Microb Drug Resist. 2007;13:114-8.
  19. BEN ACHOUR N, MERCURI PS, BEN MOUSSA M, GALLENI M, BELHADJ O. Characterization of a novel extended-spectrum TEM-type beta-lactamase, TEM-164, in a clinical strain of Klebsiella pneumoniae in Tunisia. Microb Drug Resist. 2009; 15:195-9.
  20. BEN ACHOUR N, MERCURI P S, POWER P et al. First detection of CTX-M-28 in a Tunisian hospital from a cefotaximeresistant Klebsiella pneumoniae strain. Patho Biol (Paris) 2009; 57:343-8.
  21. MAMLOUK K, BOUTIBA-BEN BOUBAKER I, GAUTIER V et al. Emergence and outbreaks of CTX-M beta-lactamaseproducing Escherichia coli and Klebsiella pneumoniae strains in a Tunisian hospital. J Clin Microbiol 2006; 44:4049-56.
  22. BOUALLEGUE-GODET O, BEN SALEM Y, FABRE L et al. Nosocomial Outbreak Caused by Salmonella enterica Serotype Livingstone Producing CTX-M-27 Extended-Spectrum ß- Lactamase in a Neonatal Unit in Sousse, Tunisia. J Clin Microbiol 2005; 43:1037-47.
  23. CHOUCHANI C, BERLEMONT R, MASMOUDI A et al. A novel extended-spectrum TEM-type ß-Lactamase, TEM-138, from Salmonella enterica Serovar Infantis. Antimicrob Agents Chemother 2006; 50: 3183-85.
  24. CHOUCHANI C, BEN-ACHOUR N, M'CHAREK A, BELHADJ O. Cefotaxime and ceftazidime-resistant Escherichia coli isolate producing TEM-15 beta-lactamase from a Tunisian hospital. C R Biol. 2007;330:565-70.
  25. BOUROUIS A, DUBOIS V, COULANGE L et al. First report of CTX-M-9 in a clinical isolate of Enterobacter cloacae in a Tunisian hospital. Pathol Biol (Paris). 2011; 59187-91.
  26. MANSOUR W, DAHMEN S, POIREL L et al. Emergence of SHV-2a extended-spectrum beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a university hospital in Tunisia. Microb Drug Resist. 2009;15:295-301.
  27. KALAI BLAGUI S, ACHOUR W, ABBASSI MS, BEJAOUI M, ABDELADHIM A, BEN HASSEN A. Nosocomial outbreak of OXA-18-producing Pseudomonas aeruginosa in Tunisia. Clin Microbiol Infect. 2007;13:794-800.
  28. LAHLAOUI H, POIREL L, MOUSSA MB, FERJANI M, OMRANE B, NORDMANN P. Nosocomial dissemination of extended-spectrum ‚-lactamase VEB-1a-producing Providencia stuartii isolates in a Tunisian hospital. Eur J Clin Microbiol Infect Dis. 2011; 30:1267-70.
  29. PITOUT JD. Infections with extended-spectrum beta-lactamaseproducing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 2010;70:313-33.
  30. CANTON R, COQUE TM. The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 2006;9:466-75.
  31. DAHMEN S, BETTAIEB D, MANSOUR W, BOUJAAFAR N, BOUALLÈGUE O, ARLET G. Characterization and molecular epidemiology of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in a Tunisian University Hospital. Microb Drug Resist 2010;16:163-70.
  32. BEN SLAMA K, BEN SALLEM R, JOUINI A et al. Diversity of Genetic Lineages Among CTX-M-15 and CTX-M-14 Producing Escherichia coli Strains in a Tunisian Hospital. Curr Microbiol. 2011;62:1794-801.
  33. KARIM A, POIREL L, NAGARAJAN S, NORDMANN P. Plasmid mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol Lett 2001; 201: 237-41.
  34. BOUTIBA-BEN BOUBAKER I, AMINE S. Alerte aux nouvelles carbapénémases: faut-il s'en inquiéter ? Tunis Med. 2010; 88:687-9.
  35. NORDMANN P. Résistance aux carbapénèmes chez les bacilles à Gram négatif. Med Sci (Paris). 2010; 26:950-9.
  36. BEN ABDALLAH H, NOOMEN S, BEN ELHADJ KHELIFAA,SAHNOUN O, ELARGOUBI A, MASTOURI M. Profil de sensibilité aux antibiotiques des souches de Pseudomonas aeruginosa isolées dans la région de Monastir. Med Mal Infect 2008, 38 :554-6.
  37. MANSOUR W, POIREL L, BETTAIEB D, BOUALLEGUE O, BOUJAAFAR N, NORDMANN P. Metallo-beta-lactamaseproducing Pseudomonas aeruginosa isolates in Tunisia. Diagn Microbiol Infect Dis. 2009; 64:458-61.
  38. BEN HAJ KHALIFA A, VU-THIEN H, POURCEL C, KHEDHER M, MASTOURI M, MOISSENET D. Caractérisation phénotypique et génotypique (randomly amplified polymorphic DNA analysis et multiple-locus variable-number tandem-repeat analysis) de 96 isolats cliniques de Pseudomonas aeruginosa à l'hôpital F. Bourguiba (Monastir, Tunisie). Pathol Biol (Paris). 2010; 58:84-8.
  39. THABET L, TURKI A, BEN REDJEB S, MESSADI A. Profil bactériologique et résistance aux antibiotiques des bactéries isolées dans un service de réanimation des brûlés durant deux ans. Tunis Med. 2008; 86:1051-4.
  40. RHOMBERG PR, JONES RN. Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008). Diagn Microbiol Infect Dis. 2009; 65:414-26.
  41. HAMMAMI S, GAUTIER V, GHOZZI R, DA COSTA A, BENREDJEB S, ARLET G. Diversity in VIM-2-encoding class 1 integrons and occasional bla SHV2a carriage in isolates of a persistent, multidrug-resistant Pseudomonas aeruginosa clone from Tunis. Clin Microbiol Infect. 2010; 16:189-93.
  42. AMAZIAN K, FENDRI C, MISSOUM MF et al. Multicenter pilot survey of resistant bacteria in the Mediterranean area. Eur J Clin Microbiol Infect Dis. 2006;25: 340-3.
  43. BEN OTHMAN A, ZRIBI M, MASMOUDI A, ABDELLATIF S, BEN LAKHAL S, FENDRI C. Phenotypic and molecular epidemiology of Acinetobacter baumannii strains isolated in Rabta Hospital, Tunisia. Arch Inst Pasteur Tunis. 2007; 84:11-9.
  44. BEN HAJ KHALIFA A, KHEDHER M. Profil de sensibilité aux antibiotiques des souches d'Acinetobacter baumannii isolées dans la région de Mahdia. Med Mal Infect. 2010;40:126-8.
  45. WALSH TR. Clinically significant carbapenemases: an update. Curr Opin Infect Dis. 2008;21: 367-71.
  46. MANSOUR W, POIREL L, BETTAIEB D, BOUALLEGUE O, BOUJAAFAR N, NORDMANN P. Metallo-beta-lactamaseproducing Pseudomonas aeruginosa isolates in Tunisia. Diagn Microbiol Infect Dis. 2009; 64:458-61.
  47. HAMMAMI S, GHOZZI R, BEN REDJEB S. Epidémie à Pseudomonas aeruginosa de sérotype O4 produisant une métalloß- lactamase de type VIM-2. Rev Tun Infect. 2010 ; 4 (Suppl. N°1):29.
  48. KTARI S, MNIF B, ZNAZEN A et al. Diversity of ‚-lactamases in Pseudomonas aeruginosa isolates producing metallo-‚- lactamase in two Tunisian hospitals. Microb Drug Resist. 2011;17:25-30.
  49. SAMUELSEN O, TOLEMAN MA, SUNDSFJORD A et al. Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion. Antimicrob Agents Chemother. 2010; 54:346-52.
  50. KTARI S, ARLET G, MNIF B et al. Emergence of multidrugresistant Klebsiella pneumoniae isolates producing VIM-4 metallo-beta-lactamase, CTX-M-15 extended-spectrum betalactamase, and CMY-4 AmpC beta-lactamase in a Tunisian university hospital. Antimicrob Agents Chemother 2006; 50:4198-201.
  51. KTARI S, MNIF B, LOUATI F, et al. Spread of Klebsiella pneumoniae isolates producing OXA-48 {beta}-lactamase in a Tunisian university hospital. J Antimicrob Chemother. 2011; 66:1644-6.
  52. MANSOUR W, POIREL L, BETTAIEB D, BOUALLEGUE O, BOUJAAFAR N, NORDMANN P. Dissemination of OXA-23- producing and carbapenem-resistant Acinetobacter baumannii in a University Hospital in Tunisia. Microb Drug Resist. 2008; 14:289-92.
  53. POIREL L, MANSOUR W, BOUALLEGUE O, NORDMANN P. Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97. Antimicrob Agents Chemother. 2008; 52:1613-7.
  54. HAMMAMI S, GHOZZI R, BEN HASSEN A, MILED D, SLIM A, BEN REDJEB S. Epidémie à Acinetobacter baumannii multirésistant dans le service de réanimation à l'hôpital Charles Nicolle de Tunis. Rev Tun Infect. 2010 ; 4 (Suppl. N°1):29.
  55. COURVALIN P, PHILIPPON A. Mécanismes biochimiques de la résistance bactérienne aux agents antimicrobiens. In Léon Le Minor, Michel Véron. Bactériologie médicale. Paris : Médecine- Sciences, Flammarion, 2ème édition, 1989: 332-55.
  56. CATTOIR V, NORDMANN P. Plasmid-mediated quinolone resistance in gram-negative bacterial species: an update. Curr Med Chem. 2009;16:1028-46.
  57. PATERSON DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Infect Control 2006;34 (5 Suppl 1):S20-8; discussion S64-73.
  58. NORDMANN P, POIREL L. Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother. 2005; 56:463-9.
  59. BOUTIBA-BEN BOUBAKER I, GHOZZI R, JOUAIHIAWet al. Résistance bactérienne aux antibiotiques en Tunisie: données de 1999 A 2003. Rev Tun Infectiol. 2007, 1:5 - 11.
  60. BEN ABDALLAH H., SAHNOUN O., BEN ROMDHANE F et al. Profil de sensibilité aux antibiotiques des entérobactéries uropathogènes isolées dans la région de Monastir. Rev Tun Infectiol. 2008, 2 : 5-8.
  61. THABET L, MESSADI AA, MEDDEB B, MBAREK M, TURKI A, BEN REDJEB S. Profil bactériologique des infections urinaires chez la femme à l'Hôpital Aziza Othmana : étude à propos de 495 cas. Tunis Med. 2010; 88:898-901.
  62. BEN HAJ KHALIFAA, KHEDHER M. Fréquence et résistance aux antibiotiques des bactéries uropathogènes à l'hôpital universitaire Tahar Sfar de Mahdia. Rev Tun Infect. 2010, 4 :57 - 61.
  63. BEN HAJ KHALIFA A, KHEDHER M. Epidémiologie des souches de Klebsiella spp. uropathogènes productrices de ßlactamases à spectre élargi dans un hôpital universitaire Tunisien, 2009. Pathol Biol (Paris). 2012; 60 (2):e1-5.
  64. DAHMEN S, POIREL L, MANSOUR W, BOUALLÈGUE O, NORDMANN P. Prevalence of plasmid-mediated quinolone resistance determinants in Enterobacteriaceae from Tunisia. Clin Microbiol Infect. 2010; 16:1019-23.
  65. ABBASSI MS, RUIZ E, SAENZ Y, MECHERGUI A, BEN HASSEN A, TORRES C. Genetic background of quinolone resistance in CTX-M-15-producing Klebsiella pneumonia and Escherichia coli strains in Tunisia. J Chemother. 2010; 22:66-7.